SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-22-002655
Filing Date
2022-04-22
Accepted
2022-04-22 16:26:37
Documents
1

Document Format Files

Seq Description Document Type Size
1 ALPINE IMMUNE SCIENCES, INC. p22-1327sc13g.htm SC 13G 68028
  Complete submission text file 0000902664-22-002655.txt   69676
Mailing Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102
Business Address 188 EAST BLAINE ST., SUITE 200 SEATTLE WA 98102 206-788-4545
ALPINE IMMUNE SCIENCES, INC. (Subject) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88896 | Film No.: 22845917
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 RIDGE TOP DRIVE HUMACAO PR 00791
Business Address 2 RIDGE TOP DRIVE HUMACAO PR 00791 703-963-7214
Lynx1 Capital Management LP (Filed by) CIK: 0001910456 (see all company filings)

IRS No.: 851134656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G